Picture of UCB SA logo

UCB UCB SA Share Price

0.000.00%
be flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+14.93%
3m+39.17%
6m+46.22%
1yr+30.58%
Volume Change (%)
10d/3m-18.49%
Price vs... (%)
52w High-1.14%
50d MA+12.76%
200d MA+41.56%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)24.32
PEG Ratio (f)0.44
EPS Growth (f)120.68%
Dividend Yield (f)1.21%
Valuation (ttm)IndustryMarket
Price to Book Value2.56
Price to Tang. Bookn/a
Price to Free Cashflow51.68
Price to Sales4.38
EV to EBITDA19.25

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.67%
Return on Equity3.8%
Operating Margin11.5%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m4,9135,3475,7775,5175,2525,597.796,3092.54%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+4.42+0.88+25.84-54.22-45.38+202.01+59.07n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of UCB SA EPS forecast chart

Profile Summary

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
January 1st, 1970
Public Since
January 2nd, 1987
No. of Employees
9,083
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
be flag iconEuronext - Brussels
Shares in Issue
189,750,583
Blurred out image of a map
Address
Allee de la Recherche, 60, ANDERLECHT, 1070
Web
https://www.ucb.com
Phone
+32 25599999
Contact
Antje Witte
Auditors
Mazars Reviseurs d Entreprises SCRL

UCB Share Price Performance

Upcoming Events for UCB

Ucb SA Annual Shareholders Meeting

Dividend For UCBJY.PK - 0.7248 USD

Dividend For UCB.BR - 1.3600 EUR

UCB SA Annual Shareholders Meeting

Half Year 2024 Ucb SA Earnings Release

Similar to UCB

Picture of Biosenic SA logo

Biosenic SA

be flag iconEuronext - Brussels

Picture of Fagron NV logo

Fagron NV

be flag iconEuronext - Brussels

Picture of Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Financiere de Tubize SA logo

Financiere de Tubize SA

be flag iconEuronext - Brussels

FAQ